Abstract
Recent studies have indicated that low UACR levels (<30 μg/mg) previously considered to be in the normal range ('low-grade albuminuria') are associated with cardiovascular morbidity and mortality in the general population. We studied 9,736 participants with albuminuria in the normal range from the 2011-2012 Korea National Health and Nutrition Examination Survey (KNHANES). The weighted prevalences of metabolic syndrome (MS) and the 10-year risk for coronary heart disease measured using the Framingham risk score (FRS) ≥ 20% (high risk) were 22.5 ± 0.7% and 14.5 ± 0.7%, respectively, in males and 23.3 ± 0.8% and 8.5 ± 0.4%, respectively in females. Weighted comparisons among the tertiles of UACR revealed that the prevalences of MS and high-risk FRS increased with increasing UACR (MS: males, 15.9 ± 1.1, 20.2 ± 1.2, 32.4 ± 1.5%, respectively; P < 0.001; and females, 17.6 ± 1.0, 22.7 ± 1.0, 30.2 ± 1.4%, respectively; P < 0.001. High-risk FRS: males, 9.5 ± 0.7, 12.3 ± 0.9, 22.5 ± 1.2, respectively; P < 0.001; and females, 5.8 ± 0.6, 7.9 ± 0.7, 12.0 ± 0.9%, respectively; P < 0.001). The positive association persisted after adjusting for hypertension and diabetes. The weighted comparisons among the deciles of UACR revealed that the prev...Continue Reading
References
Apr 1, 1989·Diabetologia·T DeckertA Kofoed-Enevoldsen
Feb 9, 1984·The New England Journal of Medicine·C E Mogensen
May 29, 1998·Circulation·P W WilsonW B Kannel
Apr 23, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·W F Keane, G Eknoyan
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 31, 2001·JAMA : the Journal of the American Medical Association·H C GersteinUNKNOWN HOPE Study Investigators
Oct 3, 2002·Circulation·Hans L HillegeUNKNOWN Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group
Sep 5, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Solfrid RomundstadHanne Ellekjaer
Oct 29, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Johannes F E MannUNKNOWN HOPE Investigators
Jan 17, 2004·Lancet·UNKNOWN WHO Expert Consultation
Jun 24, 2004·Circulation·Klaus KlausenJan Skov Jensen
Aug 10, 2005·Circulation·Johan ArnlövRamachandran S Vasan
Sep 8, 2005·Hypertension·Bjoern MayerJeanette Erdmann
Sep 20, 2005·Annals of Clinical Biochemistry·Edmund J LambUNKNOWN Clinical Sciences Reviews Committee of the Association for Clinical Biochemistry
Sep 27, 2005·Lancet·K George M M AlbertiUNKNOWN IDF Epidemiology Task Force Consensus Group
Jul 28, 2006·Kidney International·P Ruggenenti, G Remuzzi
Aug 2, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Wolfgang LiebHeribert Schunkert
Dec 1, 2006·Atherosclerosis·Ki Chul SungSeungho Ryu
May 5, 2007·The American Heart Hospital Journal·Brian A HemannAllen J Taylor
Jul 11, 2008·Mayo Clinic Proceedings·John Danziger
Aug 20, 2010·The Journal of Clinical Endocrinology and Metabolism·Yun HuangGuang Ning
Dec 14, 2012·Kidney & Blood Pressure Research·Young-Hoon LeeMin-Ho Shin
Jun 12, 2013·The Laryngoscope·Anil K LalwaniMichael Weitzman
Jun 28, 2013·PloS One·Jie ZhangYufang Bi
Oct 1, 2013·Circulation·Daniel H KatzSanjiv J Shah
Citations
Nov 7, 2015·Annals of Medicine·Seok Hui KangJun Young Do
Feb 26, 2016·International Urology and Nephrology·Kayoung Lee, Jinseung Kim
Dec 22, 2016·Scientific Reports·Chun-Chin ChangShing-Jong Lin
Apr 2, 2017·Primary Care Diabetes·Koh-Eun ShinYang-Hyun Kim
Jun 21, 2016·Annals of Medicine·Seok Hui KangKyu Hyang Cho
Dec 23, 2016·PloS One·Gyu Ah KimChan Yun Kim
Nov 12, 2016·Endocrinology and Metabolism·Hee Jung AhnHak Yeon Bae
Nov 25, 2020·BMC Endocrine Disorders·Wei ZhuGuang Wang